High incidence of meropenem resistance among α-hemolytic streptococci in children with cancer

Pediatrics International

Volumn 51, Issue 1, 2009, Pages 103-106

  Abe, Masako ^a   Kamijo, Takehiko ^a,b,d   Matsuzawa, Shigeyuki ^a   Miki, Jun ^a   Nakazawa, Yozo ^a   Sakashita, Kazuo ^a   Okabe, Tadashi ^a   Honda, Takayuki ^a   Mitsuyama, Jun Ichi ^c   Koike, Kenichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA CANCER CENTER   (Japan)

^c Toyama Chemical   (Japan)

^d Chiba Cancer Center Research Institute   (Japan)

Author keywords

hemolytic streptococci; Antimicrobial resistance; Children with febrile neutropenia; Empirical therapy

Indexed keywords

CEFTAZIDIME; COTRIMOXAZOLE; MEROPENEM; PIPERACILLIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEBRILE NEUTROPENIA; HOSPITAL DISCHARGE; HUMAN; INFANT; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MOUTH FLORA; PRIORITY JOURNAL;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INFANT; INFANT, NEWBORN; NEOPLASMS; NEUTROPENIA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; THIENAMYCINS;

EID: 60949099558     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02663.x     Document Type: Article

References (21)

1. Kanamaru A, Tatsumi Y. Microbiological data for patients with febrile neutropenia. Clin. Infect. Dis. 2004 39 (Suppl. 1 S7 10.
2. Gamis AS, Howells WB, DeSwarte-Wallace J, Feusner JH, Buckley JD, Woods WG. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: A report from the Children's cancer group study CCG-2891. J. Clin. Oncol. 2000 18 : 1845 55.
3. Marron A, Carratala J, Gonzalez-Barca E, Fernandez-Sevilla A, Alcaide F, Gudiol F. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin. Infect. Dis. 2000 31 : 1126 30.
4. Edwards JR. Meropenem: A microbiological overview. J. Antimicrob. Chemother. 1995 36 (Suppl. A 1 17.
5. Bradley JS, Garau J, Lode H, Rolston KV, Wilson SE, Quinn JP. Carbapenems in clinical practice: A guide to their use in serious infection. Int. J. Antimicrob. Agents. 1999 11 : 93 100.
6. Richard P, Amador Del Valle G, Moreau P et al. Viridans streptococcal bacteraemia in patients with neutropenia. Lancet 1995 345 : 1607 9.
7. Hughes WT, Armstrong D, Bodey GP et al. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin. Infect. Dis. 1997 25 : 551 73.
8. Raad II., Escalante C, Hachem RY et al. Treatment of febrile neutropenic patients with cancer who require hospitalization: A prospective randomized study comparing imipenem and cefepime. Cancer 2003 98 : 1039 47.
9. Feld R, DePauw B, Berman S, Keating A, Ho W. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: A randomized, double-blind trial. J. Clin. Oncol. 2000 18 : 3690 98.
10. Shah PM, Heller A, Fuhr HG et al. Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients. Infection 1996 24 : 480 84.
11. Cometta A, Calandra T, Gaya H et al. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Antimicrob. Agents Chemother. 1996 40 : 1108 15.
12. Georgopapadakou NH, Smith SA, Cimarusti CM, Sykes RB. Binding of monobactams to penicillin-binding proteins of Escherichia coli and Staphylococcus aureus: Relation to antibacterial activity. Antimicrob. Agents Chemother. 1983 23 : 98 104.
13. Dowson CG, Coffey TJ, Kell C, Whiley RA. Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae. Mol. Microbiol. 1993 9 : 635 43.
14. Carsenti-Etesse HD, Durant J, De Salvador F et al. In-vitro development of resistance to beta-lactam antibiotics in Streptococcus pneumoniae. J. Antimicrob. Chemother. 1995 36 : 417 23.
15. Paik J, Kern I, Lurz R, Hakenbeck R. Mutational analysis of the Streptococcus pneumoniae bimodular class A penicillin-binding proteins. J. Bacteriol. 1999 181 : 3852 6.
16. Sotiropoulos SV, Jackson MA, Woods GM, Hicks RA, Cullen J, Freeman AI. Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr. Infect. Dis. J. 1989 8 : 755 8.
17. Weisman SJ, Scoopo FJ, Johnson GM, Altman AJ, Quinn JJ. Septicemia in pediatric oncology patients: The significance of viridans streptococcal infections. J. Clin. Oncol. 1990 8 : 453 9.
18. Gamis AS, Howells WB, DeSwarte-Wallace J, Feusner JH, Buckley JD, Woods WG. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: A report from the Children's cancer group study CCG-2891. J. Clin. Oncol. 2000 18 : 1845 55.
19. Mayer RJ, Davis RB, Schiffer CA et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N. Engl. J. Med. 1994 331 : 896 903.
20. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer: A trial of oral penicillin V or placebo combined with pefloxacin. JAMA 1994 272 : 1183 9.
21. de Jong P, de Jong M, Kuijper E, van der Lelie J Evaluation of penicillin G in the prevention of streptococcal septicemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy. Eur. J. Clin. Microbiol. Infect. Dis. 1993 12 : 750 55.